Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.359, 2002-01, pp. : 7-7
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Infliximab worth it for ankylosing spondylitis in Canada . . .
Inpharma, Vol. 1, Iss. 1501, 2005-01 ,pp. :
Access to resources
Recommend
Infliximab not worth it for third-party payers in Canada
Inpharma, Vol. 1, Iss. 1334, 2002-01 ,pp. :
Infliximab worth it for Crohn's disease in the UK
Inpharma, Vol. 1, Iss. 1515, 2005-01 ,pp. :
Varicella vaccination worth it in Canada
Inpharma, Vol. 1, Iss. 1352, 2002-01 ,pp. :
HPV vaccination likely to be well worth it in Canada
Inpharma, Vol. 1, Iss. 1597, 2007-01 ,pp. :